March 22, 2023
3 min read
Steg PG, et al. Highlighted Original Research: Ischemic Heart Disease and the Year in Review. Presented at: American College of Cardiology Scientific Session; March 4-6, 2023; New Orleans (hybrid meeting).
Disclosures: REDUCE-IT was funded by Amarin. Steg reports receiving consultant fees/honoraria from Amarin, AstraZeneca, Bayer, Bristol Myers Squibb, Boehringer Ingelheim, Idorsia, Novartis, Novo Nordisk, Pfizer, PhaseBio, Regeneron and Sanofi Aventis; receiving research grants from Bayer, Merck, Sanofi Aventis and Servicer and speaking for Amgen.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Back to Healio
NEW ORLEANS In patients with elevated triglycerides and recent ACS, icosapent ethyl reduced risk for first and total ischemic events compared with placebo, according to new data from the REDUCE-IT trial.
As Healio previously reported, in the main results of REDUCE-IT, icosapent ethyl (Vascepa, Amarin), a pharmaceutical-grade omega-3 fatty acid, was superior to placebo for reducing risk for ischemic events in patients with elevated triglycerides at high CV risk despite statin therapy. P. Gabriel Steg, MD, chief of the cardiology department at Hpital Bichat, Paris, and professor of cardiology at the Universit de Paris, presented at the American College of Cardiology Scientific Session a post hoc analysis of REDUCE-IT covering 840 patients from the trial who had ACS, defined as MI or unstable angina, within 12 months before enrollment.
Steg told Healio that the post hoc analysis was undertaken because the main results showed that the icosapent ethyl group had elevated risk for atrial fibrillation or flutter, as has typically been observed with omega-3 fatty acids, and modestly elevated risk for bleeding compared with the placebo group.
Because of that, there were concerns that in patients with recent ACS who are particularly high risk for cardiovascular events, who have a higher risk for atrial fibrillation and who often receive intensive antithrombotic therapy including dual antiplatelet therapy, there might be a greater propensity for bleeding or atrial fibrillation or flutter, and it was uncertain whether benefit would be less, equal to or larger than in the overall population, he said in an interview.
Among the cohort, the median age was 59.5 years, 77% were men, 36.9% had diabetes, 99.9% were on statin therapy and 95.8% were on antiplatelet therapy. The primary endpoint was a composite of CV death, nonfatal MI, nonfatal stroke, coronary revascularization or unstable angina.
Steg and colleagues found that at a median follow-up of 5 years, compared with the placebo group, the icosapent ethyl group had 37% reduced risk for first primary endpoint event (HR = 0.63; 95% CI, 0.48-0.84; P = .002) and 36% reduced risk for total primary endpoint events (RR = 0.64; 95% CI, 0.45-0.9; P = .01).
In patients with recent ACS, the absolute risk reduction of first events with icosapent ethyl at 5 years was 9.3% and the number needed to treat to present one first event was 11, which Steg said was remarkable, whereas in patients with ACS more than 12 months before enrollment, the absolute risk reduction of first events with icosapent ethyl at 5 years was 4.7% and the number needed to treat to present one first event was 21 (P for interaction = .16), according to the researchers.
Among those with recent ACS, the icosapent ethyl group was more often hospitalized for AF or flutter (4.8% vs. 1.7%; P = .01), and there was no difference between the groups in bleeding rates (icosapent ethyl, 6.9%; placebo, 8.1%; P = .6), Steg and colleagues found.
It seems that icosapent ethyl is remarkably beneficial in this subgroup of patients and is safe, so [there is] no reason to deny those patients, withhold therapy or delay starting therapy with icosapent ethyl, Steg told Healio.
In fact, Steg said, We should be particularly careful not to miss these patients early on because of the magnitude of the benefit in that high-risk patient population. This seems to be an effective preventive measure to take in post-ACS patients in those who are eligible: statin-treated adults post-ACS with an LDL between 40 mg/dL and 100 mg/dL and elevated triglycerides between 150 mg/dL and 500 mg/dL. Weve computed that this is approximately one of eight patients. So its not for everybody, but for those who qualify, theres quite a good deal there.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Back to Healio
Go here to see the original:
Icosapent ethyl reduces ischemic events in high-risk patients with ... - Healio
- Sep 13, 2024 This Week in Cardiology Podcast - Medscape - September 15th, 2024 [September 15th, 2024]
- A glimpse into the future: FDA has cleared multiple AR, VR tools for cardiology - Cardiovascular Business - September 15th, 2024 [September 15th, 2024]
- StopAfib.org and Leading Cardiology Experts Urge Afib Patients to Be Active in Getting the Right Care - PR Newswire - September 15th, 2024 [September 15th, 2024]
- 2024 ESC Clinical Practice Guidelines for the Management of Elevated Blood Pressure and Hypertension - European Society of Cardiology - September 2nd, 2024 [September 2nd, 2024]
- Avoiding Surgery with Interventional Cardiology - WKYT - September 2nd, 2024 [September 2nd, 2024]
- Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London - PR Web - September 2nd, 2024 [September 2nd, 2024]
- Obesity Care, Preventive Cardiology, and Technology Take Center Stage at ESC Congress 2024 - AJMC.com Managed Markets Network - September 2nd, 2024 [September 2nd, 2024]
- Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the... - September 2nd, 2024 [September 2nd, 2024]
- Aug 02, 2024 This Week in Cardiology Podcast - Medscape - August 5th, 2024 [August 5th, 2024]
- Zing Health, Story Health Partner To Bring Cardiology Support to At-Risk Members - MedCity News - August 5th, 2024 [August 5th, 2024]
- Cardiology team performs new renal denervation procedure to treat resistant hypertension - UC Davis Health - August 5th, 2024 [August 5th, 2024]
- American College of Cardiology Announces Care of the Athletic Heart - Diagnostic and Interventional Cardiology - June 1st, 2024 [June 1st, 2024]
- May 31 2024 This Week in Cardiology - Medscape - June 1st, 2024 [June 1st, 2024]
- Personalised Cardiology - The Future Of Heart Health - BW Healthcare - June 1st, 2024 [June 1st, 2024]
- Sulphur Springs cardiology services to expand with creation of Heart and Vascular Institute - The Sulphur Springs News-Telegram - June 1st, 2024 [June 1st, 2024]
- DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology | DAIC - Diagnostic and Interventional Cardiology - June 1st, 2024 [June 1st, 2024]
- World Heart Federation honors cardiologist Valentin Fuster for lifetime of service - Cardiovascular Business - June 1st, 2024 [June 1st, 2024]
- Cardiologists ID signs of widespread heart disease in ancient mummies - Cardiovascular Business - June 1st, 2024 [June 1st, 2024]
- Cardiology Adventist Today - Adventist Today - June 1st, 2024 [June 1st, 2024]
- Study Led by Saint Luke's Mid America Heart Institute Finds Widespread Evidence of Heart Disease in Ancient ... - Saint Luke's Health System - June 1st, 2024 [June 1st, 2024]
- Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active - Diagnostic and Interventional Cardiology - June 1st, 2024 [June 1st, 2024]
- AI-Powered Ultrasound Device Enhances Cardiac Monitoring for Chemotherapy Patients - Diagnostic and Interventional Cardiology - June 1st, 2024 [June 1st, 2024]
- Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation - Mount Sinai - June 1st, 2024 [June 1st, 2024]
- Penn State Health teams rally to reopen Berks Cardiology facility in record time following burst water line - Penn State Health News - May 12th, 2024 [May 12th, 2024]
- May 10 2024 This Week in Cardiology - Medscape - May 12th, 2024 [May 12th, 2024]
- Claudia G Gidea MD | Cardiology-Advanced Heart Failure and Transplant | Newark NJ - RWJBarnabas Health - May 12th, 2024 [May 12th, 2024]
- American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic ... - Diagnostic and Interventional Cardiology - May 12th, 2024 [May 12th, 2024]
- The push for an independent cardiology board continues - Cardiovascular Business - May 12th, 2024 [May 12th, 2024]
- CB cardiologist facing sex crimes with 10-year-old appears in court - Port City Daily - May 12th, 2024 [May 12th, 2024]
- Cardiologists want better data on how legal marijuana will impact heart health in the US - Cardiovascular Business - May 12th, 2024 [May 12th, 2024]
- Cardiologist charged with 9 more sex crimes as police search his home and private practice - Cardiovascular Business - May 12th, 2024 [May 12th, 2024]
- Applications of Nanotechnology in the Field of Cardiology - Cureus - April 15th, 2024 [April 15th, 2024]
- Tri-City Cardiology's Ambulatory Surgical Center (ASC) Leads the Way in Revolutionizing Heart Failure Management - PR Newswire - April 15th, 2024 [April 15th, 2024]
- Watchdog group calls out risks associated with private equity in cardiology, other specialties - Cardiovascular Business - April 15th, 2024 [April 15th, 2024]
- Heart health: Cardiologist shares impact of advanced wearable technology on patient monitoring - News9 LIVE - April 15th, 2024 [April 15th, 2024]
- Apr 12 2024 This Week in Cardiology - Medscape - April 15th, 2024 [April 15th, 2024]
- TAVR Found Non-Inferior to SAVR for Low-Risk Patients - Diagnostic and Interventional Cardiology - April 15th, 2024 [April 15th, 2024]
- Telemedicine Strategy After MI Scores a Win in TELE-ACS - TCTMD - April 15th, 2024 [April 15th, 2024]
- Global Interventional Cardiology Devices Market Projected to Reach $21.9 Billion by 2030 - GlobeNewswire - April 15th, 2024 [April 15th, 2024]
- Impact of Interatrial Shunt May Vary by Heart Failure Type - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- SGLT-2 Inhibitors Show Mixed Results After Heart Attack - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1, A Building Block of HDL Cholesterol - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Association of Black Cardiologists' "We Are The Faces" Campaign Unveils New Videos for Black Maternal Health Week - PR Newswire - April 7th, 2024 [April 7th, 2024]
- UNC Hospitals Performs First Transcatheter Tricuspid Valve Replacement in North Carolina | Newsroom - UNC Health and UNC School of Medicine - April 7th, 2024 [April 7th, 2024]
- Cardiawave is Presenting the 30-day Follow-up Results from its Valvosoft Pivotal Study on the Teatment of Severe ... - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- Real-world Evidence at the American College of Cardiology Scientific Session ACC.24 to Demonstrate Positive Impact ... - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24 - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Medicare drops AUC requirement for advanced imaging, ASNC celebrates - Cardiovascular Business - April 7th, 2024 [April 7th, 2024]
- Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions - Yale School of Medicine - April 7th, 2024 [April 7th, 2024]
- Getting Too Little Sleep Linked to High Blood Pressure - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- What's Going to Be Hot at ACC 2024 - TCTMD - April 7th, 2024 [April 7th, 2024]
- E-cigarette use linked to increased risk of heart failure, large study finds - News-Medical.Net - April 7th, 2024 [April 7th, 2024]
- Osso VR and ACC to Develop Cardiac Procedure Training with VR - HIT Consultant - April 7th, 2024 [April 7th, 2024]
- Kapil Yadav, M.D., Joins UAMS to Lead Nuclear Cardiology and Vascular Medicine Program - UAMS News - March 19th, 2024 [March 19th, 2024]
- Doctors form new coalition focused on reducing private equity's role in cardiology, other healthcare specialties - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Beth Israel Deaconess Medical Center cardiologist to be honored by American Heart Association - American Heart Association - March 19th, 2024 [March 19th, 2024]
- March 19 Doctors on Call Will Focus on Cardiology - KRSL - March 19th, 2024 [March 19th, 2024]
- Cardiologist shares his long journey from Libya to United States - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Cardiologists share historic research that led to FDA's long-awaited approval of coronary DCB - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Most physicians think private equity is bad for healthcare - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Meth-Related Cardiomyopathy: Where the Biggest Clusters Are - Medpage Today - March 19th, 2024 [March 19th, 2024]
- Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports - Diagnostic and Interventional Cardiology - March 19th, 2024 [March 19th, 2024]
- SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement - Diagnostic and Interventional Cardiology - March 19th, 2024 [March 19th, 2024]
- Intravascular imaging during PCI in heart disease patients improves survival, reduces adverse outcomes - News-Medical.Net - March 19th, 2024 [March 19th, 2024]
- PA Martine Altieri Brings an Obesity Medicine Clinic to Her Cardiology Patients - AAPA - March 11th, 2024 [March 11th, 2024]
- WEGOVY APPROVED FOR HEART RISK: U-Mich cardiology, obesity medicine experts available for interview - Newswise - March 11th, 2024 [March 11th, 2024]
- AHA Sums Up AI's Potential in Cardiology, but Also the Hurdles Ahead - TCTMD - March 11th, 2024 [March 11th, 2024]
- Houston cardiology-focused tech platform exits to private equity, plans to scale - InnovationMap - March 11th, 2024 [March 11th, 2024]
- The Daylight Saving Time Health Effects You Might Not Be Expecting, According to a Cardiology Specialist (Exclusive) - PEOPLE - March 11th, 2024 [March 11th, 2024]
- How a big CMS update on carotid stenting could impact interventional cardiology - Cardiovascular Business - March 11th, 2024 [March 11th, 2024]
- Global Cardiology Medical Imaging Informatics Market - Cloud-powered Telecardiology to Improve Access to Healthcare - PR Newswire - March 11th, 2024 [March 11th, 2024]
- Valley Health cardiologist talks regional heart health | Nvdaily | nvdaily.com - Northern Virginia Daily - March 11th, 2024 [March 11th, 2024]
- With the correct research, AI in pediatric cardiology has great potential - Contemporary Pediatrics - March 11th, 2024 [March 11th, 2024]
- Top in cardiology: Cannabis use, heat exposure associated with higher stroke risk - Healio - March 11th, 2024 [March 11th, 2024]
- Researcher promotes subsidies to bring cardiac care closer to home in rural areas - Montana Right Now - March 11th, 2024 [March 11th, 2024]
- Cardiologist aims to improve care, reduce costly air transport - The Taos News - March 11th, 2024 [March 11th, 2024]
- Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk ... - Diagnostic and... - February 29th, 2024 [February 29th, 2024]
- Even Modest Lp(a) Elevations Bode Poorly for Cardiovascular Health - Medpage Today - February 29th, 2024 [February 29th, 2024]